Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs
Tóm tắt
The objective of this study was to examine the impact of an academic detailing programme in primary care in Norway on the prescribing rate of diclofenac, naproxen and non-steroidal anti-inflammatory drugs (NSAIDs) in total. An academic detailing programme was delivered to general practitioners (GPs) in two Norwegian cities. The key message was to avoid diclofenac and COX-2 inhibitors and to use naproxen as the NSAID of choice. We analysed prescription data for 12 months before and after the programme to estimate its impact, using interrupted time series to control for underlying trends, and using the rest of Norway as a comparator. The primary outcome was change in the proportion of the population filling a prescription for diclofenac; secondary outcomes were change in naproxen prescribing and change in total NSAID prescribing. Controlling for baseline trends, and relative to changes in the rest of Norway, there was a statistically significant reduction in the prescribing rate of diclofenac in both cities (− 18% and − 16%, respectively) immediately after the intervention. The impact of the programme on prescribing of diclofenac was maintained by the end of the 12 month follow-up period. An increase in the prescribing of naproxen was observed in both cities. The programme had no impact on the overall rate of prescribing of NSAIDs. Academic detailing was effective in changing the choice of prescribed NSAID amongst Norwegian GPs. Academic detailing is potentially an important method for providing GPs with independent, evidence-based updates on pharmacotherapy to improve prescribing.
Tài liệu tham khảo
Kongkaew C, Noyce PR, Ashcroft DM (2008) Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother 42(7):1017–1025. https://doi.org/10.1345/aph.1L037
Wester K, Jonsson AK, Spigset O, Druid H, Hagg S (2008) Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol 65(4):573–579. https://doi.org/10.1111/j.1365-2125.2007.03064.x
Kearney PM, Baigent C, Godwin J, Halls H, Emberson JR, Patrono C (2006) Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 332(7553):1302–1308. https://doi.org/10.1136/bmj.332.7553.1302
McGettigan P, Henry D (2011) Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies. PLoS Med 8(9):e1001098. https://doi.org/10.1371/journal.pmed.1001098
Trelle S, Reichenbach S, Wandel S, Hildebrand P, Tschannen B, Villiger PM, Egger M, Juni P (2011) Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis. BMJ 342:c7086. https://doi.org/10.1136/bmj.c7086
Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, Bombardier C, Cannon C, Farkouh ME, FitzGerald GA, Goss P, Halls H, Hawk E, Hawkey C, Hennekens C, Hochberg M, Holland LE, Kearney PM, Laine L, Lanas A, Lance P, Laupacis A, Oates J, Patrono C, Schnitzer TJ, Solomon S, Tugwell P, Wilson K, Wittes J, Baigent C (2013) Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet 382(9894):769–779. https://doi.org/10.1016/s0140-6736(13)60900-9
European Medicines Agency (28.06.2013) New safety advice for diclofenac – CMDh endorses PRAC recommendation
Statens legemiddelverk (25.06.2013) Nye anbefalinger for diklofenak
The Norwegian Prescription Database (NorPD) (Reseptregisteret) (2017) www.reseptregisteret.no.
Avorn J (2017) Academic detailing: “marketing” the best evidence to clinicians. JAMA 317(4):361–362. https://doi.org/10.1001/jama.2016.16036
Avorn J, Soumerai SB (1983) Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based “detailing”. N Engl J Med 308(24):1457–1463. https://doi.org/10.1056/nejm198306163082406
Figueiras A, Sastre I, Tato F, Rodriguez C, Lado E, Caamano F, Gestal-Otero JJ (2001) One-to-one versus group sessions to improve prescription in primary care: a pragmatic randomized controlled trial. Med Care 39(2):158–167
van Eijk ME, Avorn J, Porsius AJ, de Boer A (2001) Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing. BMJ 322(7287):654–657
May FW, Rowett DS, Gilbert AL, McNeece JI, Hurley E (1999) Outcomes of an educational-outreach service for community medical practitioners: non-steroidal anti-inflammatory drugs. Med J Aust 170(10):471–474
Bruyndonckx R, Verhoeven V, Anthierens S, Cornelis K, Ackaert K, Gielen B, Coenen S (2018) The implementation of academic detailing and its effectiveness on appropriate prescribing of pain relief medication: a real-world cluster randomized trial in Belgian general practices. Implement Sci 13(1):6. https://doi.org/10.1186/s13012-017-0703-8
Taljaard M, McKenzie JE, Ramsay CR, Grimshaw JM (2014) The use of segmented regression in analysing interrupted time series studies: an example in pre-hospital ambulance care. Implement Sci 9:77. https://doi.org/10.1186/1748-5908-9-77
Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D (2002) Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 27(4):299–309
Jandoc R, Burden AM, Mamdani M, Levesque LE, Cadarette SM (2015) Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations. J Clin Epidemiol 68(8):950–956. https://doi.org/10.1016/j.jclinepi.2014.12.018
Linden A (2015) Conducting interrupted time-series analysis for single- and multiple-group comparisons. Stata J 15(2):480–500
O’Brien MA, Rogers S, Jamtvedt G, Oxman AD, Odgaard-Jensen J, Kristoffersen DT, Forsetlund L, Bainbridge D, Freemantle N, Davis DA, Haynes RB, Harvey EL (2007) Educational outreach visits: effects on professional practice and health care outcomes. The Cochrane database of systematic reviews (4):Cd000409. doi:https://doi.org/10.1002/14651858.CD000409.pub2
Dreischulte T, Donnan P, Grant A, Hapca A, McCowan C, Guthrie B (2016) Safer prescribing--a trial of education, informatics, and financial incentives. N Engl J Med 374(11):1053–1064. https://doi.org/10.1056/NEJMsa1508955
Van Hoof TJ, Harrison LG, Miller NE, Pappas MS, Fischer MA (2015) Characteristics of academic detailing: results of a literature review. Am Health Drug Benefits 8(8):414–422
Van Hoof TJ, Miller NE, Meehan TP (2013) Do published studies of educational outreach provide documentation of potentially important characteristics? Am J Med Qual 28(6):480–484. https://doi.org/10.1177/1062860613476335
Yeh JS, Van Hoof TJ, Fischer MA (2016) Key features of academic detailing: development of an expert consensus using the Delphi method. Am Health Drug Benefits 9(1):42–50